Inflationary storm clouds will continue to buffet global pharma industry in 2023
Pharmaceutical Technology
JANUARY 16, 2023
However, a looming risk on the horizon in 2023 is that the economic pain may produce downstream effects on global pharmaceutical supply chain networks. A worst-case scenario could also involve some pharmaceutical production in China being diverted to domestic use in early 2023.
Let's personalize your content